Literature DB >> 2742404

Circadian rhythm of serum cytidine deaminase in patients with rheumatoid arthritis during rest and exercise.

P W Thompson1, I T James, S Wheatcroft, R Pownall, C G Barnes.   

Abstract

Circadian rhythm of serum cytidine deaminase and C reactive protein was assessed in 11 inpatients with rheumatoid arthritis who were crossed between 24 hours of bed rest and 24 hours of normal ward activity. Blood was taken at six hourly intervals and the results analysed by fitting sine waves with an assumed period of 24 hours to the measured concentrations. Cytidine deaminase after activity, but not at rest, showed circadian variation, with a 24 hour mean level of 17.4 units (normal 3-13 units) and an amplitude of 1.1 units. The circadian variation, defined as the curve's peak to trough difference as a percentage of the 24 hour mean, was 12.3% and occurred at 1208 hours. C reactive protein showed no significant circadian rhythm, in keeping with published findings. The timing of the peak in serum cytidine deaminase concentrations after a period of morning physiotherapy, but not during the bedrest morning, suggests that exercise accounts for the circadian rhythm, probably by increasing the lymphatic clearance from inflamed joints.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2742404      PMCID: PMC1003795          DOI: 10.1136/ard.48.6.502

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  9 in total

1.  Serum cytidine deaminase levels after withdrawal of non-steroidal anti-inflammatory treatment in rheumatoid arthritis.

Authors:  P W Thompson; J R Kirwan; D D Jones; H L Currey
Journal:  Ann Rheum Dis       Date:  1988-04       Impact factor: 19.103

2.  [Circadian rhythms of the so-called inflammation proteins in healthy subjects].

Authors:  B Bruguerolle; G Bouvenot; C Arnaud; F Lévy; M Mechkouri; R Bartolin; R Peronne
Journal:  Rev Rhum Mal Osteoartic       Date:  1986-05

3.  An assessment of grip strength measurement in rheumatoid arthritis.

Authors:  P Lee; A Baxter; W C Dick; J Webb
Journal:  Scand J Rheumatol       Date:  1974       Impact factor: 3.641

4.  A simple, direct, and sensitive technique for measurement of specific protein in dilute solution.

Authors:  R F Ritchie
Journal:  J Lab Clin Med       Date:  1967-09

5.  Diurnal variation of erythrocyte sedimentation rate related to feeding.

Authors:  R K Mallya; H Berry; B E Mace; F C de Beer; M B Pepys
Journal:  Lancet       Date:  1982-02-13       Impact factor: 79.321

6.  Methods for cosinor-rhythmometry.

Authors:  W Nelson; Y L Tong; J K Lee; F Halberg
Journal:  Chronobiologia       Date:  1979 Oct-Dec

7.  Circadian variation in disease activity in rheumatoid arthritis.

Authors:  J A Harkness; M B Richter; G S Panayi; K Van de Pette; A Unger; R Pownall; M Geddawi
Journal:  Br Med J (Clin Res Ed)       Date:  1982-02-20

8.  Circadian variation in biochemical assessments used to monitor rheumatoid arthritis.

Authors:  N G Sitton; A J Taggart; J S Dixon; K E Surrall; H A Bird
Journal:  Ann Rheum Dis       Date:  1984-06       Impact factor: 19.103

9.  Cytidine deaminase activity as a measure of acute inflammation in rheumatoid arthritis.

Authors:  P W Thompson; D D Jones; H L Currey
Journal:  Ann Rheum Dis       Date:  1986-01       Impact factor: 19.103

  9 in total
  5 in total

1.  Increased serum cytidine deaminase activity in gout and articular chondrocalcinosis.

Authors:  J Rovenský; M Stancíkova; K Bosmanský; M Kovalancík
Journal:  Ann Rheum Dis       Date:  1991-09       Impact factor: 19.103

2.  Cytidine deaminase in polymyalgia rheumatica and elderly onset rheumatoid arthritis.

Authors:  Sergio Paira; Susana Roverano; Oscar Rillo; Alejandra Barrionuevo; Stella Mahieu; Néstor Millen
Journal:  Clin Rheumatol       Date:  2005-01-22       Impact factor: 2.980

3.  Determinants of the interindividual variability in serum cytidine deaminase activity of patients with solid tumours.

Authors:  R Cohen; L H Preta; V Joste; E Curis; O Huillard; A Jouinot; C Narjoz; A Thomas-Schoemann; A Bellesoeur; M Tiako Meyo; J Quilichini; D Desaulle; I Nicolis; A Cessot; M Vidal; F Goldwasser; J Alexandre; B Blanchet
Journal:  Br J Clin Pharmacol       Date:  2019-01-30       Impact factor: 4.335

4.  Pharmacokinetics and Pharmacodynamics with Extended Dosing of CC-486 in Patients with Hematologic Malignancies.

Authors:  Eric Laille; Tao Shi; Guillermo Garcia-Manero; Christopher R Cogle; Steven D Gore; Joel Hetzer; Keshava Kumar; Barry Skikne; Kyle J MacBeth
Journal:  PLoS One       Date:  2015-08-21       Impact factor: 3.240

Review 5.  Acute effects of exercise on pain symptoms, clinical inflammatory markers and inflammatory cytokines in people with rheumatoid arthritis: a systematic literature review.

Authors:  Christopher Balchin; Ai Lyn Tan; Joshua Golding; Lesley-Anne Bissell; Oliver J Wilson; Jim McKenna; Antonios Stavropoulos-Kalinoglou
Journal:  Ther Adv Musculoskelet Dis       Date:  2022-08-16       Impact factor: 3.625

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.